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RESULTS: Risperidone dominated all comparators, hav-
ing the highest clinical success rate (67%), greatest num-
ber of QALYs (0.89), and lowest expected costs (CDN
$69,885) over a 1-year period. Fluphenazine had the
highest expected cost (CDN $82,264) and lowest number
of QALYs (0.85). Both oral and depot haloperidol were
associated with higher total expected costs and lower
number of QALYs than risperidone. 
CONCLUSIONS: The use of risperidone in place of halo-
peridol in Canada would be associated with annual sav-
ings of CDN $832 million in hospital expenditures, CDN
$113 million in incremental drug expenditures, and CDN
$180 million in annual incremental community care ex-
penses. Prospective validation of our findings, as well as
comparisons with the US and Europe, may be warranted.
ECONOMIC AND OUTCOMES STUDY RESULTS 
FOR DIABETES AND INFECTIOUS DISEASE
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OBJECTIVES: To investigate patterns and costs of self-
monitoring of blood glucose, and its effect on glycemic
control, among insulin-using diabetic patients in Tayside,
Scotland.
METHODS: The population-based DARTS diabetes da-
tabase was used to identify all insulin-using patients diag-
nosed with type 1 or type 2 diabetes prior to 1993. The
numbers of glucose-monitoring test strips dispensed in
1993–1995 were determined from the MEMO-dispensed
prescribing database, and average costs per patient calcu-
lated. The effect of self-monitoring on glycemic control
was investigated in a linear regression model (with
HbA1c as the outcome variable). Independent variables
were numbers of strips dispensed in the 6 months prior to
the HbA1c reading, age, sex, and deprivation.
RESULTS: Among 807 patients with type 1 diabetes,
15% obtained no test strips, 20% obtained enough strips
to test glucose daily, and 1% for four times daily. The
corresponding figures for the 1,240 insulin-using patients
with type 2 diabetes were 30% (no strips) and 12%
(daily tests). Age and deprivation influenced strip uptake.
Average costs/patient/year were £64.40 for type 1 diabe-
tes and £44.80 for type 2 diabetes, compared with £409
for self-monitoring four times daily (recommended in the
DCCT). For 258 patients with type 1 diabetes who had
HbA1c values recorded, there was an association be-
tween strip uptake and glycemic control (p  0.001),
with an estimated decrease in HbA1c of 0.7% for every
180 test strips dispensed. There was no such association
for 529 insulin-using patients with type 2 diabetes. 
CONCLUSIONS: Self-monitoring of blood glucose im-
proves glycemic control in type 1 diabetes, but a minority
of patients self-monitor regularly. Costs are moderate
compared with other costs of diabetes care.
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BACKGROUND: Patients with diabetic foot ulcers re-
quire long-term management by community-based health-
care providers. To determine the amount of health re-
sources used by patients with foot ulcers, we constructed a
patient-held booklet for recording ambulatory care re-
source use alongside a multinational trial (contacts, dress-
ings, topical medications).
OBJECTIVE: To evaluate the acceptability and com-
pleteness of the booklet.
METHOD: Thirty-seven patients in five study centers (in
the UK and Spain) were asked to use the booklet for 4
weeks. Local center coordinators interviewed patients
and clinicians and transferred data from the booklet onto
the trial economic case report form (CRF).
RESULTS: Thirty-four (92%) patients returned the
booklet to local coordinators; two had been admitted to
hospital; one was lost to follow-up. Of patients, 91%
found the booklet easy to use, and 94% remembered to
carry the booklet with them most of the time. Thirty
(91%) participating clinicians reported that the booklet
was easy to use. Comments about the booklet included:
(a) size of the text: too small; (b) volume: too bulky; (c)
look-up list of dressings and topical medications: difficult
to use. Of 277 contacts with clinicians reported in the
booklets, 256 (92%) were transferred to the CRF. Partic-
ipants recorded 1,004 dressing changes and 1,065 appli-
cations of topical medications in the booklets, 95% and
98% of which were transferred to the CRF. The number
of contacts recorded in the booklet was found to be con-
sistent with an independent report from participating
clinicians in 18 out of 19 cases for which information
was provided.
CONCLUSION: The patient-held booklet is an accept-
able data collection instrument, which with minor modi-
fications is suitable for use in ambulatory care settings.
